SCHEMBL9560065

SCHEMBL9560065

C#CCCCCCCCCCOc1ccccc1C=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
HPGD P15428 1/20 0.62
HTT P42858 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
PTGDR2 Q9Y5Y4 1/20 0.49
MAPT P10636 1/20 0.48
KMT2A Q03164 4/20 0.45
MEN1 O00255 2/20 0.45
RAD52 P43351 1/20 0.45
POLB P06746 2/20 0.43
KDM4E B2RXH2 1/20 0.43
RECQL P46063 1/20 0.43
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
MAOB P27338 2/20 0.41
SRC P12931 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPC1 O15118 2/20 0.39
PTK2B Q14289 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29953484 0.88 ALDH1A1 (0.69) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
SCHEMBL13305834 0.86 ALDH1A1 (0.83) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
SCHEMBL21828406 0.86 ALDH1A1 (0.83) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
SCHEMBL7656765 0.86 ALDH1A1 (0.83) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
SCHEMBL8372730 0.84 ALDH1A1 (0.87) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
SCHEMBL5805320 0.80 ALDH1A1 (0.87) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
SCHEMBL4442746 0.80 NPC1 (0.59) ALDH1A1HPGDHTTSMN1; SMN2KMT2A
SCHEMBL825342 0.80 ALDH1A1 (0.66) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
SCHEMBL29953636 0.80 ALDH1A1 (0.66) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
SCHEMBL7378757 0.80 ALDH1A1 (0.71) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0358240-B1 INTERMEDIATES FOR THE PREPARATION OF LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1993-06-09 EP disclosed
US-5034537-A Alpha-methyl-4-halobenzenemethanamine salts of acids for cardiovascular disorders, respiratory system disorders and antiallergens SMITHKLINE BEECHAM CORPORATION (US) 1991-07-23 US disclosed
US-4939279-A Leukotriene antagonists SMITHKLINE BEECHAM CORPORATION (US) 1990-07-03 US disclosed
EP-0202759-B1 LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1990-06-20 EP disclosed
EP-0358240-A2 Intermediates for the preparation of leukotriene antagonists SMITHKLINE BEECHAM CORPORATION (US) 1990-03-14 EP disclosed
US-4874792-A RESPIRATORY SYSTEM DISORDERS SMITHKLINE BECKMAN CORPORATION (US) 1989-10-17 US disclosed
US-4820719-A ANTIALLERGENS, ANTIINFLAMMATORY, ANTIISCHEMIC AND HYPOTENSIVE AGENTS SMITHKLINE BECKMAN CORPORATION (US) 1989-04-11 US disclosed
EP-0202759-A2 Leukotriene antagonists SMITHKLINE BEECHAM CORPORATION (US) 1986-11-26 EP disclosed